Tag: Q3
Medanta posts 19% YoY growth in Q3 FY26 revenue despite Noida...
Strong patient volumes and higher realizations drive performance; new Noida hospital impacts profitability in its first full quarter of operations
Emcure posts strong Q3FY26 results with ₹2,363 crore & 20.4 %...
The company's domestic business recorded sales of ₹1,025 crore, up 15.4 percent year-on-year
Tata Elxsi delivers healthy growth in Q3 FY’26
Revenue from operations grows 3.9% QoQ, with EBITDA margin increasing by 220 bps
Orchid Pharma registers 26% PAT in Q3 of FY25
Q3 results show strong momentum in YoY-9 month backed by expansion of its anti-microbial portfolio
Godavari Biorefineries achieves 12% YoY revenue growth in Q3 FY25
Revenue from operations rose to ₹447.3 crore, up from ₹398.0 crore in Q3 FY24, with an EBITDA of ₹39.7 crore and a Profit After Tax (PAT) of ₹5.8 crore.
Emcure Pharma registers 18% revenue growth, 30% PAT in Q3 of...
Revenue from operations at Rs 1,963 Cr, up 17.7% YoY and PAT at 156Cr, up 30.3% YoY
Zydus Life net profit up 30% to Rs 1,024 crore, revenue...
The company’s revenue from operations stood at Rs 5,269 crore, up 17% as compared to Rs 4,505 crore reported in Q3 FY24
Zydus posts consolidated revenues of Rs. 3655 crores in Q3
The company filed 12 additional ANDAs with the USFDA during the quarter and received 9 new product approvals (including 5 tentative approvals) from the USFDA.